People with inflammatory bowel disease (IBD) face a heightened risk of colorectal cancer, yet early detection remains a challenge. Researchers…
Browsing: Clinical Updates
Could a bispecific antibody revolutionize inflammatory bowel disease (IBD) treatment? Mozart Therapeutics is presenting new preclinical data on MTX-201, an…
The article “Quality Indicators for Upper GI Endoscopy,” published in The American Journal of Gastroenterology in February 2025, emphasizes the…
A revolutionary blood test could transform how colorectal cancer is detected—without the need for invasive procedures. Oxford BioDynamics’ (OBD) EpiSwitch®…
A groundbreaking study suggests that a simple low-dose aspirin regimen could slash the risk of colon cancer returning by more…
Once considered rare, eosinophilic esophagitis (EoE) is now rapidly increasing in prevalence, making it a frequent challenge in gastroenterology, allergy,…
Could a weight-loss procedure do more than just shed pounds? New research suggests bariatric surgery slashes the risk of pancreatic…
A multicenter study published in Clinical and Translational Gastroenterology highlights critical delays in initiating advanced therapies for inflammatory bowel disease…
BMS presented data from the CheckMate-8HW trial, demonstrating that the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) significantly improves outcomes…
Disorders of gut–brain interaction (DGBI) often overlap with non-gastrointestinal conditions such as fibromyalgia, headaches, gynecological and urological disorders, sleep disturbances,…